首页 | 本学科首页   官方微博 | 高级检索  
检索        

90Y标记单克隆抗体CD45的研究
引用本文:扶云碧,李贵平,孟凡义.90Y标记单克隆抗体CD45的研究[J].南方医科大学学报,2006,26(8):1230-1232.
作者姓名:扶云碧  李贵平  孟凡义
作者单位:南方医科大学南方医院,血液科,广东,广州,510515;南方医科大学南方医院,核医学科,广东,广州,510515
基金项目:广东省自然科学基金;广东省广州市科技计划
摘    要:目的 制备^90Y标记的CD45单克隆抗体,为用^90Y-CDTPA-CD45mAb治疗急性白血病奠定基础。方法 利用环酐DTPA为络合剂,螯合^90Y与CD45mAb,并对^90Y-CDTPA-CD45mAb的标记率、放化纯度、稳定性、比活度、免疫活性进行检测。结果 在CDTPA与IgG的最佳摩尔比为20:1的条件下,^90Y-CDTPA-CD45mAb的标记率为95%,放化纯度达99.8%,稳定性良好,比活度为1.9mCi/mg,免疫活性与未标记的CD45mAb相比无明显差异。结论 ^90Y-CDTPA-CD45mAb是一个较理想的靶向治疗制剂.可以用于下一步的急性白血病治疗研究。

关 键 词:90Y  CD45单抗  环酐DTPA
文章编号:1673-4254(2006)08-1230-03
收稿时间:2005-12-20
修稿时间:2005年12月20

Labeling of CDTPA-dianhydride-coupled CD45 monoclonal antibody with yttrium-90
FU Yun-bi,LI Gui-ping,MENG Fan-Yi.Labeling of CDTPA-dianhydride-coupled CD45 monoclonal antibody with yttrium-90[J].Journal of Southern Medical University,2006,26(8):1230-1232.
Authors:FU Yun-bi  LI Gui-ping  MENG Fan-Yi
Institution:Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. hnfyb@yahoo.com.cn
Abstract:OBJECTIVE: To explore the methods for labeling CDTPA-coupled CD45 monoclonal antibody (mAb) with yttrium-90 ((90)Y) for potential acute myeloid therapy. METHODS: CD45 mAb was labeled with (90)Y by CDTPA and the labeling rate, radiochemical purity, final specific activity, and immunological activity of the mAb were detected. RESULTS: With the optimal molar ratio of CDTPA/Ab at 20:1, the labeling rate was 95%, radiochemical purity 99.8%, and final specific activity 1.9 mCi/mg. This conjugate was stable in vitro with comparable immunological activity in comparison with unlabeled CD45 mAb. CONCLUSION: (90)Y-CDTPA-CD45 mAb possesses good properties as an ideal targetting therapeutic agent for acute leukemia.
Keywords:90Y
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号